Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Prof Luisa De Cola, University of Milan and Mario Negri Institute, Italy

Prof. Luisa De Cola is an accomplished chemist known for her interdisciplinary research in supramolecular and materials chemistry, with applications in biomedical fields. She holds a Laurea in Chemistry from the University of Messina and has held prestigious positions at institutions like the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at Istituto Mario Negri, Milan. With over 400 published papers and 42 patents, she has received numerous awards, including the 2020 Gold Medal “Giulio Natta” and 2014 Chevalier de la Légion d’Honneur. 🏅🔬💡

Publication Profile

Google Scholar

Education

Prof. Luisa De Cola, a renowned scientist, earned her Laurea in Chemistry from the University of Messina in 1983. She has held various prestigious academic roles, including Post-doctoral Fellow at Virginia Commonwealth University, and visiting scientist positions at UCLA, Harvard, and MIT. From 1986 to 1990, she worked as a researcher at the National Research Council in Bologna. She later served as a Full Professor at the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at the Mario Negri Institute. 🧪🔬🌍

Experience

Prof. Luisa De Cola is a renowned academic and researcher currently serving as a Full Professor at the University of Milan, Italy, since 2020. She is also the Director of the “Materials for Health” unit at Istituto di Ricerche Farmacologiche Mario Negri in Milan. Her distinguished career includes previous roles at prestigious institutions such as the University of Amsterdam, University of Münster, and University of Strasbourg. Prof. De Cola has held notable positions, including chairing molecular photonic materials and nanoelectronics. Her research contributions span nanoelectronics, nanophotonics, and biomaterials. 🌍📚🔬👩‍🔬

Research achievements

Prof. Luisa De Cola’s research is known for its multidisciplinary approach, driven by curiosity and fundamental exploration, often with practical applications. Her work spans supramolecular and material chemistry, focusing on functional luminescent and electro-luminescent assemblies, optical and electroluminescent devices, and dynamic (breakable) materials for biomedical applications. With over 400 published papers in peer-reviewed journals (H-index = 88, over 27,000 citations on Scopus), her research has been featured in prestigious journals like Nature and Nature Chemistry. Her contributions continue to shape innovations in materials science and biomedicine. 🌟🧪🔬📚💡💉

Peer recognition

Prof. Luisa De Cola is a distinguished chemist, awarded numerous prestigious prizes throughout her career. Her accolades include the 1993 Chemistry Prize from the Accademia di Scienze Fisiche e Matematiche di Napoli, the 1995 Federchimica National Prize, and the 2009 European Research Council Advanced Grant Award (Magic). In 2011, she received the IUPAC Prize for distinguished women in chemistry, followed by the 2014 Chevalier de la Légion d’Honneur. Other honors include the 2019 Izatt–Christensen Award, 2020 Giulio Natta Gold Medal, and the 2024 Centenary Prize for Chemistry and Communication. She is also an Honorary Professor at Tianjin University and a Doctor Honoris Causa from Universidad Internacional Menéndez Pelayo. 🏆🔬🎖️🌟

Research Focus

Prof. Luisa De Cola’s research focuses on advanced materials, particularly in the development of luminescent and electrochemical systems for various applications. Her work involves the synthesis and characterization of ruthenium and osmium complexes, often in multi-component systems, exploring their electrochemical behavior, absorption spectra, and photoinduced processes. She investigates biomimetic self-assembly for imaging applications, the creation of highly luminescent lanthanide complexes, and photoinduced energy and electron transfer in dinuclear complexes. Her studies have applications in photonic devices, electroluminescence, and molecular imaging. Her work intersects chemistry, material science, and biological applications. 🔬💡🔋✨

Publication Top Notes

Ruthenium (II) and osmium (II) bis (terpyridine) complexes in covalently-linked multicomponent systems: synthesis, electrochemical behavior, absorption spectra, and …

Controlling and imaging biomimetic self-assembly

White‐light emission from an assembly comprising luminescent iridium and europium complexes

Highly luminescent, triple-and quadruple-stranded, dinuclear Eu, Nd, and Sm (III) lanthanide complexes based on bis-diketonate ligands

When self-assembly meets biology: luminescent platinum complexes for imaging applications

Photoinduced energy and electron transfer processes in rigidly bridged dinuclear Ru/Os complexes

Electroluminescent device with reversible switching between red and green emission

 

Prof.Aleksandr Urakov|Drug Repurposing | Best Researcher Award

Prof.Aleksandr Urakov, Drug Repurposing ,Best Researcher Award

Prof.Aleksandr Urakov atIzhevsk State Medical Academy,Russia

PROFILE  

scopus

Orcid

Academic Leadership 🏫

Professor Aleksandr Urakov serves as the head of the Department of General and Clinical Pharmacology at Izhevsk State Medical Academy. His leadership has been instrumental in shaping the department into a center of excellence in pharmacological research and education.

Innovative Contributions 🧠

As an inventor, Professor Urakov holds over 270 patents and has published more than 200 scientific articles . His research in temperature pharmacology and drug repurposing  has led to significant advancements, including the development of the floating tablet and warm alkaline hydrogen peroxide solutions .

Recognition and Honors 🎖️

For his remarkable contributions, Professor Urakov has been awarded the Order of the Badge of Honor and holds the prestigious title of Honored Inventor of the Russian Federation . His work continues to influence and inspire the medical community globally.

Research and Innovations🔬 :

Professor Urakov invented the floating tablet and discovered warm alkaline hydrogen peroxide solutions (WAHPSs), which include new drug subgroups like bruise bleaches, pus-dissolving drugs (pyolytics), and oxygen-producing antihypoxants. These innovations offer alternatives to ECMO for hypoxemia in COVID-19 asphyxia.

🎓Publication 

Comment: Balanced Salt Solutions for Critically Ill Patients: Nonplused and Back to Basics

Thermal imaging of local skin temperature as part of quality and safety assessment of injectable drugs

    • Authors :Urakov, A., Urakova, N., Samorodov, A., Suntsova, D., Muhutdinov, N..
    • Journal   :Heliyon
    • Year       : 2024

Understanding burn injuries in children – A step toward prevention and prompt first aid

  • Authors  :Urakov, A.L., Suntsova, D.O., Yagudin, I.I.
  • Journal    :Burns
  • Year         :  2023

ASSESSMENT OF FETAL RESISTANCE TO HYPOXIA USING THE STANGE TEST AS AN ADJUNCT TO APGAR SCALE ASSESSMENT OF NEONATAL HEALTH STATUS

  • Authors  :Shabanov, P.D., Urakov, A.L., Urakova, N.A.
  • Journal   :Medicinskij Akademiceskij Zurnal,
  • Year        :   2023

Prospects for the pharmacological validation of the use of platelets as a “peripheral model” of neurons

Assoc Prof Dr.Guanyu Chen|Drug Delivery Systems | Best Researcher Award

Assoc Prof Dr.Guanyu Chen, Drug Delivery Systems,Best Researcher Award

Assoc Prof Dr.Guanyu Chen, at Sun Yat-Sen University School of Pharmaceutical Sciences Shenzhen,China

PROFILE  

scopus

🧪 Research Focus :

Associate Prof. Guanyu Chen is an expert in Drug Delivery and Immunochemotherapy at the School of Pharmaceutical Sciences, Sun Yat-sen University.

🎓 Education and Professional Experience :

He earned his Bachelor’s (2005-2008), Master’s (2009-2012), and PhD (2012-2016) degrees from the University of Auckland, New Zealand. Following his PhD, he worked as a Postdoctoral Fellow at the same university from 2017 to 2019. During this time, he also served as a Research Assistant at Ancare Scientific Ltd, Douglas Ltd, Alleva Animal Health Ltd, and Kimberly Clack Ltd. In 2019, he joined Sun Yat-sen University, China, as an Associate Professor.

💰 Research Funding :

Prof. Chen has received significant funding for his research, including the National Natural Science Foundation of China in 2022 (82273871), the Guangdong Basic and Applied Basic Research Foundation in 2021 (2021A1515110006), the Shenzhen Science and Technology Program in 2020 (GXWD20201231165807008), the 67th Batch Postdoc Research Foundation of China in 2019 (2020M673030), and the Kimberly Clarks Pharmaceutics Research Fund, USA in 2016 (32715.001).

🏅 Patents and Awards :

His achievements include two national invention patents and several prestigious awards: Overseas Senior Talent of Shenzhen, Recruiting Outstanding Overseas Talent of Guangdong, Maurice and Phyllis Paykel Research Award, Academic Career Exploration Scholarship, Edna and Denis Moloney Scholarship, FMHS-PGSA Award from the University of Auckland, Elite Editing Thesis Write-up Scholarship from Australia, and The University of Auckland Partnership Appeal Award.

📚 Editorial Roles :

Prof. Chen contributes to the academic community as a Youth Editorial Board Member for Acta Materia Medica and the Journal of Drug Delivery and Translational Research. He also serves as a Guest Editor for the Journal of Current Drug Delivery and Pharmaceutics.

🔍 Conclusion

Associate Prof. Guanyu Chen stands out as a leading researcher in drug delivery and immunochemotherapy, with a robust academic background and extensive experience. His significant contributions to the field are supported by notable research funding and a series of prestigious awards. As a dedicated academic and editorial contributor, Prof. Chen continues to advance pharmaceutical sciences through his research, mentorship, and publication efforts.

🎓Publication 

The scaffold protein AXIN1: gene ontology, signal network, and physiological function

Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis

Cryo-Milled β-Glucan Nanoparticles for Oral Drug Delivery

  • Authors  :Chen, G., Liu, Y., Svirskis, D., Lu, W., Wen, J.
  • Journal    :Pharmaceutics
  • Year         :  2024

Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy

Development of a novel peptide targeting GPR81 to suppress adipocyte-mediated tumor progression

  • Authors  :Chen, S., Zhou, X., Li, W., Liu, J., Gao, Y.
  • Journal   :Biochemical Pharmacology
  • Year        :  2023